{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreihj45m2ins3zqdkrwpf4rr7o3od476l6dxeh4uxl6xl45tjglt5rm",
    "uri": "at://did:plc:pt4hags74g3s4ilzuwasenfd/app.bsky.feed.post/3mlegh3ltfq72"
  },
  "path": "/2026/05/07/repub/unpacking-the-fight-over-telehealth-access-to-abortion-medication/",
  "publishedAt": "2026-05-07T23:27:33.000Z",
  "site": "https://marylandmatters.org",
  "tags": [
    "Abortion Policy",
    "Health",
    "Justice",
    "5th U.S. Circuit Court of Appeals",
    "abortion drug",
    "abortion rights",
    "Danco Laboratories",
    "EMTALA",
    "GenBioPro",
    "in-person abortion",
    "Justice Samuel Alito",
    "Louisiana v. U.S. Food and Drug Administration",
    "mail-order mifepristone",
    "mifepristone",
    "misoprostol",
    "President Joe Biden",
    "reproductive rights",
    "Society of Family Planning",
    "surgical abortion",
    "telehealth"
  ],
  "textContent": "Both sides of the abortion debate are wondering what happens next in a telehealth medication court case that created chaos and confusion over the past week as one court blocked access to the abortion drug and the Supreme Court restored it -- until Monday.",
  "title": "Unpacking the fight over telehealth access to abortion medication"
}